March 2021 Volume 17, Issue 3
Volume 17, Issue 3 | March 2021
March 2021
In this Issue
Diagnostics
A different kind of TROLL
APIS and Moffitt pair up to assess TROLL lncRNAs as predictive biomarkers in cancer
Bringing down the cost of cancer?
NuView’s theranostics approach could make cancer diagnosis and treatment more affordable
Global effort on a neglected tropical disease
Health partners team up to speed up development of new schistosomiasis test
A first-in-class diagnostic for Parkinson’s disease
AC Immune Initiates Clinical Study of ACI-12589 PET imaging tracerPreclinical
Novel neuroprotection from Noveome
Data show full complement ST266 biologic offers better neuroprotection than fractionated formats
Developing antibodies against SARS-CoV-2
DIOS-202 and DIOS-203 have been engineered for high potency and potential for avoiding escape mutants
UC San Diego researchers target rare form of autism
Study could lead to future treatment for autism spectrum disorder that mostly affects girlsTools & Technology
The three dimensions: Impact, metrics, and process
Collaborative project model helps assess user experience maturity
Specifica sells antibody library platform to UCB
The Generation 3 Library Platform will boost UCB’s discovery efforts
Bringing biologics into the wearable device world
Clinical trial data demonstrate potential for BD Libertas wearable drug delivery system
Tools and services making the rounds
Find out about new offerings from BioTek, Repligen, Flow Eighteen38, and CressetClinical Trials
Antibody against Alzheimer’s
Lilly’s donanemab Phase 2 trial brings positive results
Funding the jump to digital
Series C round to support Medable's plans for improving clinical trial technologies and options
Roflumilast foam advances to Phase 3
Data show that roflumilast foam provides significant improvement for seborrheic dermatitis
Discovery
Blending datasets for better research
AI collaboration seeks to improve access to COVID-19 datasets across institutions
Single-cell sequencing vs. Schistosoma mansoni
Cell atlas of tropical disease parasite could highlight new targets for treatment
Autism answers within genetic disorders
Collaboration aims at drug discovery pipeline for monogenic causes of autism
Harnessing Electricity-Producing Bacteria
Potential exists for better detection and understanding of human diseaseSpecial Reports
Special Report on Clinical Trials: Delving into decentralization
Pandemic perils accelerate digital adoption in clinical trialsFeature
Focus Feature on Cancer
We explore advances in women’s cancers in addition to other recent oncology newsEditor's Focus
Cancer and clinical trials in the spotlight
March is still the month where we put extra attention on cancer, but the landscape is different in a pandemic
Out of order: Beyond exhausted
While there will no doubt be and end, the COVID pandemic is tiring all of us out right nowCommentary
Commentary: As COVID-19 research evolves, so too will animal models
Infectious disease researchers must expand the repertoire of animal models to advance their research
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Overcoming barriers in gene therapy
Advanced gene editing, delivery, and analytical tools are driving better gene therapies.
A multiomic approach to profiling brain tumors
Probing the molecular drivers of brain metastasis reveals novel therapeutic targets.
Enhancing immune cell profiling with digital technologies
Software innovations help researchers decode immune complexity in cancer.
